Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis

Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis

US Patent 10392378 · Granted Aug 27, 2019

Estimated economic value: $1,947,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused heterocycles as 5-HT2A receptor agonists2025
Fused heterocycles as 5-HT2A receptor agonists2025
Kinase inhibitors and methods of use thereof2025
Proteasome activity enhancing compounds2025
Proteasome activity enhancing compounds2025
Proteostasis regulators2024
Proteasome activity enhancing compounds2024
Proteasome activity enhancing compounds2024
Proteasome activity enhancing compounds2024
Proteasome activity enhancing compounds2023
Proteasome activity enhancing compounds2023
Proteasome activity enhancing compounds2023